“Persistent Supravenous Erythematous Eruption (PSEE): A Scoping Review on an Adverse Effect Related to Docetaxel Infusion”. Research, Society and Development 11, no. 5 (April 3, 2022): e21111527974. Accessed December 14, 2025. https://www.rsdjournal.org/rsd/article/view/27974.